Parabilis Medicines sets biotech record with $670m IPO - Pharmaceutical Technology

Parabilis’ US listing means the biotech IPO record has been broken twice in as many months as public listings continue hot streak. Parabilis’ US listing means the biotech IPO record has been broken twice in as many months as public listings continue hot streak. Parabilis’ IPO continues a strong 2026 for biotech listings in the US. Credit: JHVEPhoto/Shutterstock.com. Parabilis Medicines has secured the largest initial public offering (IPO) in biotech history, suggesting that an uptick of upsized public listings in the sector shows no signs of slowing. Parabilis, a US biotech specialising in cancer therapies, has offered 33.5 million shares…

Source: Pharmaceutical Technology